We are committed to enhancing the clinical skills of both practicing physicians and those still in training by providing unique educational activities that innovate, rather than duplicating available options.
About Us
The PLATO (Physicians Learning And Teaching in Oncology) Foundation is a US-based international nonprofit organization founded in July 2010. In recent years, oncology and hematology have become increasingly complex fields, and the growing number and complexity of therapeutic options available for solid tumors and hematologic malignancies have resulted in a sizable knowledge gap for many clinicians. Physicians in both academic and community practice are uncertain about many issues relating to the management of patients with solid tumors and hematologic malignancies. Among these areas of uncertainty are the screening of high-risk patients, revised staging guidelines, emerging radiotherapy techniques, patient selection for neoadjuvant therapy, implementation of novel agents into established chemo/radiotherapy regimens, and the appropriate clinical utilization of biomarkers.
The continuous rapid progress in clinical cancer research makes it increasingly difficult for practicing oncology healthcare professionals to stay abreast of the most recent advances in the treatment of cancer. Moreover, new data are not always framed in the context of the clinical practices of community physicians and other healthcare providers. The resulting delays in the flow of information are an impediment to the ability of practicing oncology healthcare professionals to become educated about the latest developments and advances and to apply them in their clinical practice.
Through the PLATO Foundation, more physicians will be afforded an opportunity to be exposed to cutting-edge clinical advances presented in a balanced and unbiased way by carefully chosen experts. “We are committed to enhancing the clinical skills of both practicing physicians and those still in training by providing unique educational activities that innovate rather than in duplicating available options,” says PLATO Chairman, Lee Lokey, MD. With the number of cancers diagnosed each year expected to increase by 45% in the next two decades, it is imperative that clinicians continue to be updated as ongoing clinical studies produce data on new agents and regimens. It is also imperative that practicing oncologists and other medical personnel be aware of emerging therapeutic strategies that are proven safe and efficacious, as well as have an in-depth understanding of treatment options and the rapid evolution of cancer management strategies.
Mission Statement
It is the mission of the PLATO Foundation to advance the medical education of emerging generations of oncology and hematology practitioners, as well as those in current practice. As therapeutic advances develop, the PLATO Foundation's objectives are centered on meeting the ongoing educational needs of oncologists and hematologists, thus, impacting the treatment of cancer and improving patient outcomes.
Vision Statement
The PLATO Foundation believes it can achieve its charitable goals by providing physicians an opportunity to evaluate and assimilate the latest clinical data presented by expert thought leaders. These data, when placed in the context of current clinical practice, will ultimately result in improved patient outcomes.

